BME103 s2013:TEMPwu3: Difference between revisions
(14 intermediate revisions by the same user not shown) | |||
Line 28: | Line 28: | ||
{| {{table}} | {| {{table}} | ||
|- | |- | ||
| Sample Name || | | Sample Name || Ave. INTDEN* || Calculated μg/mL || Conclusion (pos/neg) | ||
|- | |- | ||
| Positive Control || --- || N/A | | Positive Control || --- || --- || N/A | ||
|- | |- | ||
| Negative Control || --- || N/A | | Negative Control || --- || ---|| N/A | ||
|- | |- | ||
| Tube Label:___ Patient ID: ____ rep 1 || --- || | | Tube Label:___ Patient ID: ____ rep 1 || --- || --- || --- | ||
|- | |- | ||
| Tube Label:___ Patient ID: ____ rep 2 || --- || | | Tube Label:___ Patient ID: ____ rep 2 || --- || --- || --- | ||
|- | |- | ||
| Tube Label:___ Patient ID: ____ rep 3 || --- || | | Tube Label:___ Patient ID: ____ rep 3 || --- || --- || --- | ||
|- | |- | ||
| Tube Label:___ Patient ID: ____ rep 1 || --- || | | Tube Label:___ Patient ID: ____ rep 1 || --- || --- || --- | ||
|- | |- | ||
| Tube Label:___ Patient ID: ____ rep 2 || --- || | | Tube Label:___ Patient ID: ____ rep 2 || --- || --- || --- | ||
|- | |- | ||
| Tube Label:___ Patient ID: ____ rep 3 || --- || | | Tube Label:___ Patient ID: ____ rep 3 || --- || --- || --- | ||
|} | |} | ||
<nowiki>* Ave. INTDEN = Average of ImageJ integrated density values from three Fluorimeter images</nowiki> | |||
'''Bayesian Statistics'''<br> | '''Bayesian Statistics'''<br> | ||
These statistics are based upon all of the DNA detection system results that were obtained in the PCR lab for | These following conditional statistics are based upon all of the DNA detection system results that were obtained in the PCR lab for 20 hypothetical patients who were diagnosed as either having cancer or not having cancer.<br> | ||
Bayes Theorem equation: P(A|B) = P(B|A) * P(A) / P(B) | Bayes Theorem equation: P(A|B) = P(B|A) * P(A) / P(B) | ||
Line 85: | Line 86: | ||
==New System: Design Strategy== | ==New System: Design Strategy== | ||
<!--The whole team is responsible for completing this section. This is where you get to express/ argue why certain aspects fall under Must Have, Want, Must Not Have, or Should Avoid. List the two aspects that your team picked from each category in class.--> | <!--The whole team is responsible for completing this section. This is where you get to express/ argue why certain aspects fall under Must Have, Want, Must Not Have, or Should Avoid. List the two aspects that your team picked from each category in class. You are allowed to create new aspects, as long as they are relevant to your new design.--> | ||
'''We concluded that a good system ''Must Have'':''' | '''We concluded that a good system ''Must Have'':''' | ||
Line 146: | Line 147: | ||
<br><br> | <br><br> | ||
==New System: Protocols== | |||
''' | '''DESIGN''' | ||
<!-- | <!-- If your team decided to change the PCR and/or the Fluorimeter imaging protocols, summarize the new approaches/ features here and delete the '''We chose keep the protocols the same as the original system''' section. --> | ||
'''We chose to include these new approaches/ features''' | |||
* Feature 1 - explanation of how this addresses any of the specifications in the "New System: Design Strategy" section | |||
* Feature 2 - explanation of how this addresses any of the specifications in the "New System: Design Strategy" section | |||
* Etc. | |||
[OR] | |||
''' | <!-- If your team decided NOT to change any of the machinery/ devices, explain why here and delete the '''We chose to include these new features''' section above--> | ||
'''We chose keep the protocols the same as the original system''' | |||
* Feature 1 - explanation of how a pre-existing feature addresses any of the specifications in the "New System: Design Strategy" section | |||
* Feature 2 - explanation of how a pre-existing feature addresses any of the specifications in the "New System: Design Strategy" section | |||
* Etc. | |||
'''MATERIALS''' | |||
<!--- Place your two tables "Supplied in the kit" and "Supplied by User" here ---> | |||
'''PROTOCOLS''' | |||
* '''PCR Protocol''' | |||
<!-- Create a step-by-step procedure for setting up and running PCR reactions. Your instructions should include everything from adding reagents to the tubes, to programming the PCR machine and running the reaction.--> | |||
# Step 1 | |||
# Step 2 | |||
# Etc. | |||
* '''DNA Measurement and Analysis Protocol''' | |||
<!-- Create a step-by-step procedure for measuring DNA amplification in the PCR reactions. Your instructions should include everything from diluting the samples in SYBR Green, to placing the drops onto the fluorimeter (if your group is using the fluorimeter), to collecting and processing images in Image J. Don't forget to provide instructions on how to set up the calf thymus DNA samples for calibration, and how to convert INTDEN values into concentrations.---> | |||
# Step 1 | |||
# Step 2 | |||
# Etc. | |||
< | <br><br> | ||
==New System: Research and Development== | |||
''' | '''BACKGROUND''' | ||
<!--- A description of the | <!--- A description of the CHEK2 gene, it's associated SNP, and the cancer-related function of the gene. Use the information from your Week 13 worksheet. ---> | ||
'''DESIGN''' | |||
''' | '''Primers for PCR'''<br> | ||
<!-- If your team decided to only amplify cancer-associated DNA, list the "Cancer allele forward primer" sequence and the "Cancer allele reverse primer" sequence. Include a paragraph that explains why a disease allele will give a PCR product and the non-disease allele will not.--> | |||
<!-- | <!-- If your team chose an alternative approach to amplify the DNA, list all relevant primers. Include a paragraph that explains how your system works.--> | ||
'''Our primers address the following design needs''' | |||
* Design specification 1 - explanation of how an aspect of the primers addresses any of the specifications in the "New System: Design Strategy" section | |||
* Design specification 2 - explanation of how an aspect of the primers addresses any of the specifications in the "New System: Design Strategy" section | |||
* Etc. | |||
<br><br> | |||
==New System: Software== | |||
[THIS SECTION IS OPTIONAL. If your team has creative ideas for new software, and new software is a key component included in your new protocols, R&D, or machine design, you may describe it here. You will not receive bonus points, but a solid effort may raise your overall page layout points. If you decide not to propose new software, please delete this entire section, including the <nowiki>==New System: Software==</nowiki> header.] | |||
Latest revision as of 12:28, 11 April 2013
BME 103 Spring 2013 | Home People Lab Write-Up 1 Lab Write-Up 2 Lab Write-Up 3 Course Logistics For Instructors Photos Wiki Editing Help | |||||||||||||||||||||||||||||||||||||||||
OUR TEAMLAB 3 WRITE-UPOriginal System: PCR ResultsPCR Test Results
* Ave. INTDEN = Average of ImageJ integrated density values from three Fluorimeter images
Bayes Theorem equation: P(A|B) = P(B|A) * P(A) / P(B)
Calculation 3: The probability that the patient will develop cancer, given a cancer DNA sequence.
New System: Design StrategyWe concluded that a good system Must Have:
New System: Machine/ Device EngineeringSYSTEM DESIGN
KEY FEATURES We chose to include these new features
[OR] We chose keep the devices the same as the original system
INSTRUCTIONS
New System: ProtocolsDESIGN We chose to include these new approaches/ features
[OR] We chose keep the protocols the same as the original system
PROTOCOLS
New System: Research and DevelopmentBACKGROUND
DESIGN
New System: Software[THIS SECTION IS OPTIONAL. If your team has creative ideas for new software, and new software is a key component included in your new protocols, R&D, or machine design, you may describe it here. You will not receive bonus points, but a solid effort may raise your overall page layout points. If you decide not to propose new software, please delete this entire section, including the ==New System: Software== header.]
|